{"disease":{"id":"desmoid-tumor","name":"desmoid tumor"},"drugs":{"marketed":[{"drug_id":"nirogacestat","indication_name":"progressing desmoid tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ogsiveo","generic_name":"NIROGACESTAT","company_name":"Springworks","drug_phase":"marketed","molecular_target":"","drug_class":"Gamma Secretase Inhibitor [EPC]","quality_score":53,"revenue":null,"mechanism":"Nirogacestat works by blocking the gamma secretase enzyme, which is involved in the development and progression of desmoid tumors."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07461246","title":"Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04289077","title":"Quality of Life of Patients With Desmoid-type Fibromatosis","phase":"","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04851119","title":"Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":147,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT03785964","title":"Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"SpringWorks Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06258421","title":"Burden of Disease and Living Situation in Desmoid Patients","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT05561036","title":"A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":72,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07176689","title":"Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"SpringWorks Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06195085","title":"CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03190174","title":"Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Sarcoma Oncology Research Center, LLC","has_results":true},{"nct_id":"NCT05949099","title":"Study of Cryoablation and Nirogacestat for Desmoid Tumor","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"Nam Bui","has_results":false},{"nct_id":"NCT06355921","title":"A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":27,"lead_sponsor_name":"Blokhin's Russian Cancer Research Center","has_results":false},{"nct_id":"NCT03802084","title":"A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Hyo Song Kim","has_results":false},{"nct_id":"NCT03459469","title":"Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Iterion Therapeutics","has_results":false},{"nct_id":"NCT07170644","title":"A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"SpringWorks Therapeutics, Inc.","has_results":false},{"nct_id":"NCT01981551","title":"Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05111964","title":"HIFU Ablation of Soft Tissue Sarcoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Oxford University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT03966742","title":"Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT05041036","title":"Individual Patient Compassionate Use of Nirogacestat","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"SpringWorks Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02955446","title":"Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Colorado, Denver","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}